波罗类激酶抑制剂通过阻止细胞循环进展来增加AAV的产生
Kaylin Fisher1, Francis Grafton1, Francesca Ispaso1
1Ascend Advanced Therapies CA Inc, Alameda, CA 94501, USA.
Molecular therapy. Methods & clinical development
|February 19, 2025
概括
研究人员确定了促进腺相关病毒 (AAV) 生产的小分子,用于基因治疗. 波罗样酶1 (PLK1) 抑制剂显著增强了AAV制造,可能降低成本.
科学领域:
- 生物技术是生物技术.
- 分子生物学分子生物学
- 基因治疗 基因治疗
背景情况:
- 再组合腺相关病毒 (rAAV) 对于基因疗法至关重要,但面临着影响可用性的制造挑战.
- 目前的生产方法在低收益率和高成本下扎,限制了治疗应用.
研究的目的:
- 发现增强腺相关病毒血清型9 (AAV9) 细胞生产的小分子.
- 确定新的战略,以提高AAV制造效率和成本效益.
主要方法:
- 采用高通量小分子选方法,使用AAV选平台的阵列定向库.
- 选了3300个小分子以确定影响AAV生产的化合物.
- 利用细胞周期和RNA测序分析来了解它的作用机制.
主要成果:
- 确定了几种类型的化合物,包括PLK1抑制剂,可以增强AAV的产生.
- 证明用HMN-214抑制PLK1显著增加了不同细胞系,载体类型和体血清型的AAV产量.
- 显示的PLK1抑制导致细胞周期在G2/M阶段停止,影响病毒的产生.
结论:
- 波罗样酶1 (PLK1) 抑制是增强腺相关病毒 (AAV) 生产的一个有前途的策略.
- 这一发现为开发更高效,更具成本效益的基因疗法的AAV制造工艺提供了潜在的途径.
关键词:
在 AAV AAV AAV 中.波罗类类酶是一种波罗类类酶.腺相关病毒的病毒.细胞周期控制细胞周期控制基因治疗的基因疗法高通量选的高通量选发展过程发展过程.小分子图书馆 - 小分子图书馆病毒载体制造 病毒载体制造更多相关视频
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
11.0K
10:49A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects TEdeff in Cancers
Published on: September 26, 2019
5.6K
相关概念视频
Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
Negative Regulator Molecules
35.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.1K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
DNA Damage can Stall the Cell Cycle
9.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.0K
Anaphase Promoting Complex
2.8K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.8K
Positive Regulator Molecules
5.3K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.3K
